New World hemorrhagic fever
Posted on by Dr. Francis Collins
Growing up in Queens, NY, Jonathan Abraham developed a love for books and an interest in infectious diseases. One day Abraham got his hands on a copy of Laurie Garrett’s The Coming Plague, a 1990s bestseller warning of future global pandemics, and he sensed his life’s calling. He would help people around the world survive deadly viral outbreaks, particularly from Ebola, Marburg, and other really bad bugs that cause deadly hemorrhagic fevers.
Abraham, now a physician-scientist at Brigham and Women’s Hospital, Boston, continues to chase that dream. With support from an NIH Director’s 2016 Early Independence Award, Abraham has set out to help design the next generation of treatments to enable more people to survive future outbreaks of viral hemorrhagic fever. His research strategy: find antibodies in the blood of known survivors that helped them overcome their infections. With further study, he hopes to develop purified forms of the antibodies as potentially life-saving treatments for people whose own immune systems may not make them in time. This therapeutic strategy is called passive immunity.
Tags: antibodies, cryo-electron microscopy, cryo-EM, Ebola, hemorrhagic fever, infectious diseases, junin virus, Marburg virus, neutralizing antibodies, New World hemorrhagic fever, NIH Director’s 2016 Early Independence Award, pandemic, passive immunity, viral hemorrhagic fever, viral pandemics, virology, virus, x-ray crystallography